Please login to the form below

Not currently logged in
Email:
Password:

HeartCel

This page shows the latest HeartCel news and features for those working in and with pharma, biotech and healthcare.

Celixir cleared to start trial of stem cell therapy for heart failure

Celixir cleared to start trial of stem cell therapy for heart failure

Previous trial demonstrated patients achieving 100% MACE free survival. UK biotech Celixir has been given a green light to start a phase IIb trial of HeartCel - its stem cell-based therapy ... The initial Heartcel trial results are very exciting, showing

Latest news

  • Cell Therapy licenses heart failure therapy in Japan Cell Therapy licenses heart failure therapy in Japan

    Additional undisclosed payments will also be forthcoming if HeartCel passes other development and regulatory milestones, as well as royalties on any future sales. ... HeartCel has been clinically tested with heart failure patients who undergo bypass

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics